Recent review articles about thyroid cancer (InTextoResearch)


InTextoResearch, scientific information agency


InTextoResearch informs on the most recent review articles in the
field of thyroid cancer:

Medullary thyroid carcinoma: surgical treatment advances.
Dionigi G, Bianchi V, Rovera F, Boni L, Piantanida E, Tanda ML,
Dionigi R, Bartalena L.
Expert Rev Anticancer Ther. 2007 Jun;7(6):877-85.

Radiation-induced thyroid cancer: what we have learned from chernobyl.
Nikiforov YE.
Endocr Pathol. 2006 Winter;17(4):307-17.

Papillary thyroid carcinoma with lymph node metastases.
Lin JD.
Growth Factors. 2007 Feb;25(1):41-9.

Staging systems for papillary thyroid carcinoma: a review and
comparison.
Lang BH, Lo CY, Chan WF, Lam KY, Wan KY.
Ann Surg. 2007 Mar;245(3):366-78.

Thyroid cancer invasion of neck structures: epidemiology, evaluation,
staging and management.
Morton RP, Ahmad Z.
Curr Opin Otolaryngol Head Neck Surg. 2007 Apr;15(2):89-94.

p53 family proteins in thyroid cancer.
Malaguarnera R, Vella V, Vigneri R, Frasca F.
Endocr Relat Cancer. 2007 Mar;14(1):43-60.

Staging systems for follicular thyroid carcinoma: application to 171
consecutive patients treated in a tertiary referral centre.
Lang BH, Lo CY, Chan WF, Lam KY, Wan KY.
Endocr Relat Cancer. 2007 Mar;14(1):29-42.

Perspectives and limitations of microarray-based gene expression
profiling of thyroid tumors.
Eszlinger M, Krohn K, Kukulska A, Jarzab B, Paschke R.
Endocr Rev. 2007 May;28(3):322-38.

The IGF-I axis in thyroid carcinoma.
Ciampolillo A, De Tullio C, Perlino E, Maiorano E.
Curr Pharm Des. 2007;13(7):729-35.

Technology insight: gene therapy and its potential role in the
treatment of medullary thyroid carcinoma.
Messina M, Robinson BG.
Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):290-301.

Defects in iodide metabolism in thyroid cancer and implications for
the follow-up and treatment of patients.

Schlumberger M, Lacroix L, Russo D, Filetti S, Bidart JM.
Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):260-9.

A therapeutic strategy for incidentally detected papillary
microcarcinoma of the thyroid.
Ito Y, Miyauchi A.
Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):240-8.

Anaplastic thyroid carcinoma: an overview.
Cornett WR, Sharma AK, Day TA, Richardson MS, Hoda RS, van Heerden JA,
Fernandes JK.
Curr Oncol Rep. 2007 Mar;9(2):152-8.

New therapeutic approaches for metastatic thyroid carcinoma.
Baudin E, Schlumberger M.
Lancet Oncol. 2007 Feb;8(2):148-56.

Evidence-based review of treatment and follow up of pediatric patients
with differentiated thyroid carcinoma.
Rachmiel M, Charron M, Gupta A, Hamilton J, Wherrett D, Forte V,
Daneman D.
J Pediatr Endocrinol Metab. 2006 Dec;19(12):1377-93.

Vandetanib (ZD6474): an orally available receptor tyrosine kinase
inhibitor that selectively targets pathways critical for tumor growth
and angiogenesis.
Herbst RS, Heymach JV, O'Reilly MS, Onn A, Ryan AJ.
Expert Opin Investig Drugs. 2007 Feb;16(2):239-49.

The role of PET in follow-up of patients treated for differentiated
epithelial thyroid cancers.
Leboulleux S, Schroeder PR, Schlumberger M, Ladenson PW.
Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):112-21.

Short-term hypothyroidism after Levothyroxine-withdrawal in patients
with differentiated thyroid cancer: clinical and quality of life
consequences.
Duntas LH, Biondi B.
Eur J Endocrinol. 2007 Jan;156(1):13-9.

BRAF mutations in papillary thyroid carcinoma.
Wojciechowska K, Lewinski A.
Endocr Regul. 2006 Dec;40(4):129-38.

Targeting BRAF in thyroid cancer.
Espinosa AV, Porchia L, Ringel MD.
Br J Cancer. 2007 Jan 15;96(1):16-20.

Diagnostic criteria in well-differentiated thyroid carcinomas.
Fonseca E, Soares P, Cardoso-Oliveira M, Sobrinho-Simoes M.
Endocr Pathol. 2006 Summer;17(2):109-17.

The role of external beam radiotherapy in the treatment of papillary
thyroid cancer.
Lee N, Tuttle M.
Endocr Relat Cancer. 2006 Dec;13(4):971-7.



(contact at InTextoResearch: Marc Lacroix, Baelen, Wallonia, Belgium -
scimedweb@xxxxxxxx)

.

Loading